FDA: AstraZeneca Ad for Crestor Misleading
266346
A newspaper advertisement for  AstraZeneca Plc's cholesterol drug Crestor that touts patient  safety is misleading and should no longer be published,  regulators warned in a letter released on Wednesday.
359683
A Johnson & Johnson JNJ.N  promotion for rheumatoid arthritis drug Remicade is misleading  because it makes unsupported claims about the drug's  effectiveness and omits important information about risks, U.S.  regulators said in a letter released on Monday.
579894
Twenty-nine patients who took AstraZeneca Plc's  cholesterol drug Crestor have developed kidney damage, a U.S. consumer group said on Friday as it called again for a ban on the medicine.
479423
AstraZeneca Plc's cholesterol-lowering drug Crestor performed better than Pfizer Inc's Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
159402
AstraZeneca&#39;s recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are &quot;false and misleading,&quot; in part because
143479
AstraZeneca Plc's cholesterol-lowering  drug Crestor performed better than Pfizer Inc's Lipitor in an  AstraZeneca-funded study of patients with metabolic syndrome,  according to results released on Monday.
75357
The recently marketed statin drug Crestor was more effective in treating high cholesterol than the competing medication Lipitor among patients with metabolic syndrome, according to a new study funded by Crestor&#39;s manufacturer.
333419
AstraZeneca's advertisements defending Crestor were criticized in part because concerns remain about the drug's safety.
179939
AstraZeneca&#39;s newest advertisements for its cholesterol-lowering drug Crestor are misleading and should be pulled from the market, consumer group Public Citizen says.
527141
LONDON - Drug manufacturer AstraZeneca PLC announced Friday that trials of its new lung cancer drug found it didn&#39;t help patients live longer.
632138
The U.S. Food and Drug  Administration warned GlaxoSmithKline Plc  on Thursday over  misleading advertisements touting its hypertension drug called  Coreg.
25832
The American Heart Association defended the drug Vytorin, an expensive drug combination for cholesterol, which was shown last week to work no better than Zocor, a cheaper alternative.
170594
Nov. 2,2004 - The Food and Drug Administration today warned consumers not to purchase or consume Actra-Rx or Yilishen, two products promoted for sale on Web sites as &quot;dietary supplements&quot; for treating erectile
161994
FDA on Tuesday made public a letter ordering Abbott Laboratories to stop circulating two advertisements for its antiretroviral drug Kaletra because the agency said the ads &quot;exaggerat[e]&quot; the drug&#39;s benefits and omit information about possible &quot;life
140812
WASHINGTON (CBS.MW) - An advisory panel to the Food and Drug Administration late Friday declined to endorse AstraZeneca&#39;s anti-stroke drug, Exanta.
177936
The Food and Drug Administration (FDA) has granted a fast track review of testosterone patches for women with low sex drive, despite concerns about insufficient data and potentially misleading marketing by their manufacturer Proctor &amp; Gamble, claim two
287842
The Food and Drug Administration has asked the maker of cholesterol-lowering medication Crestor to stop running an advertisement that makes &quot;false or misleading&quot; claims about the drug&#39;s safety.